| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | REVANCE THERAPEUTICS INC | 3,096,650 | 42,114,000 | 100.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-114526, filed 2016.07.26).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
